Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

Abbott Capitalizes On Pandemic Testing Boom; Device Sales Stay Almost Flat

Jan 27 2021

• By Reed Miller

Pyramid, cylinder and a sphere in perfect balance — • Source: shutterstock.com

Related Content

J&J Finishes Tough Year With Optimism For 2021

Jan 26 2021

CMS Extends National Medicare Coverage For Transcatheter Mitral Valve Repair

Jan 20 2021

JPM 2021: Boston Scientific, Abbott, Dexcom, Insulet, Silk Road Medical

Jan 13 2021

Medtronic Launches Trial Of Tricuspid Version Of Intrepid Transcatheter Valve

Sep 09 2020

FDA Authorizes Abbott’s '$5, 15 Minute' COVID-19 Antigen Test

Aug 27 2020

Abbott’s 3Q $8.9Bn Sales Beat Wall Street Consensus, Medtech Sales Up 3.4%

Oct 21 2020

Abbott Receives US Authorization For First 'Virtually Guided' At-Home Rapid Test

Dec 16 2020

Related Companies

Abbott

Additional Topics

Sales & Earnings Coronavirus COVID-19 Companies Business Strategies Reimbursement Research & Development Telehealth In Vitro Diagnostics Diabetic Care Infectious Diseases Cardiology Cardiovascular Medical Device

More from In Vitro Diagnostics

More from Diagnostics

Twitter feed RSS feed RSS feed

About

About UsOpens in new window
Meet the Team
AdvertiseOpens in new window
Contact Us

Account

My Account
My View
Email Preferences
Start Free TrialOpens in new window

More

Medtech Top 100 Ranking
Data Trackers
FDA Warning Letters

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window